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Macrophages Contribute to the Progression of
Infantile Hemangioma by Regulating the Proliferation
and Differentiation of Hemangioma Stem Cells
Wei Zhang1,2, Gang Chen1,2, Feng-Qin Wang1, Jian-Gang Ren1, Jun-Yi Zhu1, Yu Cai1,2, Ji-Hong Zhao2,
Jun Jia1,2 and Yi-Fang Zhao1,2
Macrophage inﬁltration has been implicated in infantile hemangioma (IH), the most common tumor of infancy.
However, the exact role of macrophages in IH remains unknown. This study aims to clarify the functional
signiﬁcance of macrophages in the progression of IH. The distribution of macrophages in human IH was
analyzed, and our results revealed that polarized macrophages were more prevalent in proliferating IHs than in
involuting IHs, which was consistent with the increased macrophage-related cytokines in proliferating IHs. In
vitro results further demonstrated that polarized macrophages effectively promoted the proliferation of
hemangioma stem cells (HemSCs) and suppressed their adipogenesis in an Akt- and extracellular signal-
regulated kinase 1/2 (Erk1/2)-dependent manner. Moreover, M2- but not M1-polarized macrophages promoted
the endothelial differentiation of HemSCs. Furthermore, mixing macrophages in a murine hemangioma model
elevated microvessel density and postponed fat tissue formation, which was concomitant with the activation of
Akt and Erk1/2 signals. Cluster analysis revealed a close correlation among the macrophage markers, Ki67,
vascular endothelial growth factor (VEGF), p-Akt, and p-Erk1/2 in human IH tissues. Collectively, our results
suggest that macrophages in IH contribute to tumor progression by promoting the proliferation and endothelial
differentiation while suppressing the adipogenesis of HemSCs. These ﬁndings indicate that targeting the
inﬁltrating macrophages in IH is a promising therapeutic approach to accelerate IH regression.
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INTRODUCTION
Infantile hemangioma (IH) is a common benign vascular
tumor of infancy that occurs in ~ 10% of Caucasians. The
tumor has been characterized by its unique life cycle, namely,
rapid growth followed by slow regression (Mulliken and
Glowacki, 1982; Mulliken et al., 2000; Buckmiller et al., 2010).
IHs are commonly harmless, but a fraction of these tumors are
destructive, disﬁguring, and even life-threatening, depending
on their sizes and locations (Pandey et al., 2008). Currently, the
pathogenesis of this tumor remains largely unknown. Further
clarifying the mechanism by which the proliferating phase
spontaneously transitions to the involuting phase is crucial for
development of speciﬁc therapies against IHs.
Using cluster of differentiation (CD)133 magnetic microbe-
ads, Khan et al. (2008) isolated immature progenitor-like cells,
which were termed hemangioma stem cells (HemSCs), from
proliferating hemangioma tissues; these cells displayed a
mesenchymal morphology with robust proliferation ability
and multi-lineage differentiation potential. Meanwhile, a
murine hemangioma model was established by sub-
cutaneously injecting HemSCs into immunodeﬁcient mice,
in which HemSCs differentiated into endothelial cells,
pericytes, and adipocytes (Khan et al., 2008; Boscolo et al.,
2011). The isolated HemSCs and the established murine
hemangioma model not only provide a powerful means to
explore the precise pathogenesis of IHs (Boscolo et al., 2011;
Smadja et al., 2014) but also offer a platform to screen
effective therapeutics against this tumor (Greenberger et al.,
2011; Wong et al., 2012; Zhang et al., 2014). However, the
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hemangioma model only contained HemSCs; thus, it cannot
reﬂect the effects of other cellular components during
IH progression. Our previous studies and that of Ritter et al.
(2006) suggested that macrophages were an important
cellular component in the pathogenesis of IHs (Jia et al.,
2008; Wang et al., 2013). In general, macrophages are
divided into two subtypes (Mantovani et al., 2013; Zhou et al.,
2014): M1-polarized macrophages (classically activated
macrophages) and M2-polarized macrophages (alternatively
activated macrophages). M1-polarized macrophages respond
to Th1 immune cells and secrete pro-inﬂammatory cytokines.
M2-polarized macrophages are induced by IL-4 and IL-13,
and are involved in wound healing and cancer formation by
secreting pro-angiogenic and anti-inﬂammatory factors.
In the present study, we systematically studied the effects of
macrophages on HemSCs both in vitro and in vivo. The
proliferation ability and differentiation potential of HemSCs
were examined in polarized macrophage-derived condi-
tioned media. The signaling pathways that were involved in
these processes were also identiﬁed and analyzed. All ﬁndings
were conﬁrmed in a murine hemangioma model. This is the
ﬁrst study to demonstrate that macrophages contribute to the
progression of IH by simultaneously promoting the proliferation
and suppressing the adipogenesis of HemSCs in an Akt- and
extracellular signal-regulated kinase 1/2 (Erk1/2)-dependent
manner. Moreover, M2-polarized macrophages promote the
endothelial differentiation of HemSCs. Therefore, targeting the
inﬁltrating macrophages in IH is a promising therapeutic
strategy to accelerate IH regression.
RESULTS
Macrophages are prevalent in proliferating IHs
CD68+ macrophages were more prevalent in proliferating IHs
than in involuting IHs (Figure 1a). These macrophages were
mostly located in the interstitial portion close to vessel struc-
tures. Immunochemical analysis of M1- and M2-polarized
macrophages with their corresponding speciﬁc markers
HLA-DR and CD163 implicated the presence of both types of
macrophages in the IH samples (Supplementary Figure 1
online). Data from double-labeling immunoﬂuorescence also
conﬁrmed the presence of M1 (CD68+HLA-DR+) and M2
(CD68+CD163+) macrophages in the IH tissues (Figure 1b).
Both M1- and M2-polarized macrophages were more
frequently found in proliferating IHs than in involuting IHs
(Figure 1c). However, more M1-polarized than M2-polarized
macrophages were found in both proliferating and involuting
IHs. We then evaluated the expression levels of several
macrophage-related cytokines in human IH tissues. Consistent
with the results from immunochemistry and immunoﬂuores-
cence, the mRNA expression levels of tumor necrosis factor-α
(TNF-α), interleukin (IL)-1β, IL-6, and transforming growth
factor-β (TGF-β) were much higher in proliferating IHs than in
involuting IHs (Figure 1d). Greenberger et al. (2010) also found
an increased expression of IL-6 in the proliferating IH samples.
Macrophages promote the proliferation of HemSCs
To evaluate the effects of the two distinctive macrophages on
the proliferation and differentiation of HemSCs, a co-culture
system of the macrophages and HemSCs was established using
the conditioned medium (CM) collected from polarized macro-
phages. Initially, HemSCs were isolated from early proliferating
IHs and veriﬁed according to a previous study (Khan et al.,
2008; Supplementary Figure 2 online). The polarized macro-
phages were induced from THP-1, a human monocyte cell line,
and the successful induction was conﬁrmed by measuring
cytokines expression (Supplementary Figure 3 online).
The effects of polarized macrophages on the proliferation
ability of HemSCs were examined using EdU incorporation
assays and 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2-H-tet-
razolium bromide (MTT) assays. As shown in Figure 2a and b,
nuclear EdU incorporation in HemSCs was increased after
they were treated with the CM derived from either M1- or M2-
polarized macrophages for 24 hours. The results of MTT
assays also demonstrated that the CM from M1- and M2-
polarized macrophages signiﬁcantly enhanced the prolifera-
tion of HemSCs in both normal (EBM-2/2% fetal bovine serum
(FBS)) and adipogenic culture environments (Figure 2c).
Moreover, western blot analysis revealed signiﬁcantly
increased expression levels of cell cycle-related proteins
cyclin D1 and phsopho-Rb (Ser807/811) in the HemSCs
treated with the CM from polarized macrophages (Figure 2d).
These ﬁndings suggest that M1- and M2-polarized macro-
phages can promote the proliferation of HemSCs.
Macrophages regulate the differentiation of HemSCs
As shown in Figure 3a, the CM from M2-polarized macro-
phages remarkably enhanced cell surface expression of CD31
in HemSCs, whereas the CM from M1-polarized macrophages
decreased CD31 expression. In addition, tube formation
assays for HemSCs revealed that the CM from M2-polarized
macrophages but not that from M1-polarized macrophages
promoted the formation of capillary-like structures (Figure 3a
and b). Meanwhile, the protein expression levels of vascular
endothelial-cadherin (VE-cadherin) and NRP2 in HemSCs
were increased when treated with the CM from M2-polarized
macrophages but were decreased when treated with the CM
from M1-polarized macrophages. Similar results were
observed for the mRNA expression levels (Figure 3c and d).
Therefore, we conclude that only M2-polarized macrophages
can promote the endothelial differentiation of HemSCs.
Interestingly, treatment with a combination of the CM from
both M1- and M2-polarized macrophages (at equal amounts)
enhanced the tube formation of HemSCs and the expression
of VE-cadherin (Supplementary Figure 4 online). This obser-
vation suggests the dominant role of M2-polarized macro-
phages in regulating the vasculogenesis of HemSCs.
We then tested whether or not macrophages can regulate
the adipogenesis of HemSCs. After being cultured in adipo-
genic medium for 14 days, HemSCs showed great potential
in differentiating into adipocytes. However, as shown in
Figure 3e and f, the CM from either M1- or M2-polarized
macrophages signiﬁcantly suppressed the adipogenesis of
HemSCs, as evidenced by the decreased Oil Red O staining.
Meanwhile, the protein expression level of peroxisome
proliferator–activated receptor-γ (PPARγ) was remarkably
reduced (Figure 3g), and the mRNA expression levels of
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Figure 1. Expression levels of polarized macrophage markers and related cytokines in human infantile hemangioma (IH) tissues. (a) Immunohistochemical
staining of CD68 in proliferating and involuting IH. (b) Double-labeling immunoﬂuorescence staining of CD68/HLA-DR for M1-polarized macrophages and
CD68/CD163 for M2-polarized macrophages in human IH. (c) Quantitative analysis of HLA-DR and CD163 positive cells per total cells in IH samples.
(d) Relative mRNA expression levels of macrophage-related cytokines, including tumor necrosis factor-α (TNF-α), IL-1β, IL-6 and transforming growth factor-β
(TGF-β), in IH samples (three samples of proliferating IHs and three samples of involuting IHs). *Po0.05; **Po0.01. Scale bar=100 μm.
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Figure 2. Conditioned medium (CM) of M1- and M2-polarized macrophages enhanced the proliferation of hemangioma stem cells (HemSCs). (a) EdU
incorporation assays of HemSCs treated with M1- or M2-CM in EBM-2/2% fetal bovine serum (FBS) and adipogenic medium for 24 hours. (b) Quantitative
analysis of EdU incorporation assays in a (n=3). (c) Cell viability of HemSCs treated with M1- or M2-CM in EBM-2/2% FBS and adipogenic medium for 24 hours
(n= 3). *Po0.05; **Po0.01 versus control group cultured in EBM-2/2% FBS; #Po0.05; ##Po0.01 versus control group cultured in adipogenic medium. (d)
Western blot for cyclin D1 and phosphor-Rb (Ser807/811) in HemSCs treated with EBM-2/2% FBS and adipogenic medium containing M1- or M2-CM for
24 hours. Scale bar=100 μm.
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PPARγ, CCAAT-enhancer-binding protein-α (C/EBPα) and LPL
were reduced after treatment with macrophage-derived CM
(Figure 3h). Thus, we conclude that polarized macrophages
can suppress the adipogenic differentiation of HemSCs. Using
293 cell-derived CM as a negative control, we veriﬁed that
only the CM from polarized macrophages could promote the
proliferation of HemSCs and regulate their differentiation,
including adipogenesis and endothelial differentiation
(Supplementary Figure 5 online). Moreover, the polarized
primary macrophages derived from mouse bone marrow
showed similar effects on HemSCs when compared with
THP-1 derived polarized macrophages (Supplementary
Figure 6 online).
Erk1/2 and Akt signaling pathways are involved in
macrophage-induced HemSC proliferation and differentiation
To understand the mechanisms by which macrophages
regulate the proliferation and differentiation of HemSCs, we
used PathScan Intercellular Signaling Arrays to screen the
signaling pathways that might be involved in these processes.
The results revealed high phosphorylation levels of Erk1/2 and
Akt, as well as the downstream targets of Akt, such as mTOR,
S6, and GSK-3β (Figure 4a), which was further conﬁrmed by
western blot analysis (Supplementary Figure 7 online).
PD98059 and LY294002, the speciﬁc small-molecule inhibi-
tors of Erk1/2 and Akt, respectively, were used to explore the
precise roles of Erk1/2 and Akt in the macrophages mediated
proliferation and differentiation of HemSCs. As shown in
Figure 4b, PD98059 (10 μM) and LY294002 (10 μM) signiﬁ-
cantly suppressed the phosphorylation of Erk1/2 and Akt,
respectively. In addition, LY294002 markedly reduced the
expression of cyclin D1 and slightly reduced the expression of
VE-cadherin and PPARγ. By contrast, PD98059 signiﬁcantly
reduced VE-cadherin expression, rescued PPARγ expression
in adipogenic culture environment and slightly increased
cyclin D1 expression. On the basis of these ﬁndings and a
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Figure 3. Polarized macrophages modulated the differentiation of hemangioma stem cells (HemSCs). (a) CD31 expression in HemSCs treated with
macrophages conditioned media (CM) in EBM-2/2% fetal bovine serum (FBS) for 48 hours. Tube formation assays of HemSCs treated for 18 hours (b) and the
quantitative analysis (c) (n=3). VE-cadherin and NRP2 protein (d) and mRNA (e) expressions in HemSCs treated as indicated in a for 24 hours. Oil red staining (f)
and quantitative analysis (g) for HemSCs treated with macrophage CM in adipogenic medium (see Materials and Methods section; n=3). Peroxisome proliferator–
activated receptor-γ (PPARγ) expression (h) and relative mRNA expression of adipogenic genes (i) in HemSCs treated with macrophage CM in adipogenic
medium for 24 hours (n= 3). *Po0.05; **Po0.01 versus control group. Scale bar= 100 μm.
W Zhang et al.
Functional Signiﬁcance of Macrophages in IH
3166 Journal of Investigative Dermatology (2015), Volume 135
Control M1-CM M2-CM
Control M1-CM M2-CM
Control M1-CM M2-CMControl M1-CM M2-CM
1
2 3EBM-2/2%FBS:
EBM-2/2%FBS:
EBM-2/2%FBS:
EBM-2/2%FBS: Adipogenic:
1. Erk1/2 (Thr202/Tyr204) 2. Akt (Thr308) 3. Akt (Ser473)
pErk1/2
Erk1/2
pAkt
Akt
Cyclin D1
VE-cadherin
α-Tubulin
α-Tubulin
Adipogenic:
PPARγ
Co
ntr
ol
M1
-CM
M2
-CM
Co
ntr
ol
M1
-CM
M2
-CM
Co
ntr
ol
M1
-CM
M2
-CM
Co
ntr
ol
M1
-CM
M2
-CM
Co
ntr
ol
M1
-CM
M2
-CM
Co
ntr
ol
M1
-CM
M2
-CM
Co
ntr
ol
M1
-CM
M2
-CM
Co
ntr
ol
M1
-CM
M2
-CM
Co
ntr
ol
M1
-CM
M2
-CM
Co
ntr
ol
M1
-CM
M2
-CM
Co
ntr
ol
M1
-CM
M2
-CM
Co
ntr
ol
M1
-CM
M2
-CM
44/42 kDa
44/42 kDa
60 kDa
60 kDa
36 kDa
130–140 kDa
52 kDa
57/53 kDa
52 kDa
Vehicle PD98059 LY294002
Vehicle PD98059 LY294002
Vehicle PD98059 LY294002 Vehicle PD98059 LY294002
Ve
hi
cl
e
PD
98
05
9
LY
29
40
02
Ve
hi
cl
e
PD
98
05
9
LY
29
40
02
Ve
hi
cl
e
PD
98
05
9
LY
29
40
02
Pe
rc
en
ta
ge
 o
f E
DU
po
sit
ive
 c
el
ls
15
10
5
0
## ##
**
**
**
**
*
** **
**
*
*
##
## ##
**
**
**
**
200
150
100
50
Tu
be
 fo
rm
at
io
n 
as
sa
ys
(pe
rce
nta
ge
 of
 co
ntr
ol)
0
150
100
50
0O
il r
ed
 s
ta
in
in
g
(pe
rce
nta
ge
 of
 co
ntr
ol)
a
b
c
d e
Figure 4. Polarized macrophages regulated the proliferation and differentiation of hemangioma stem cells (HemSCs) via activation of Akt and Erk1/2.
(a) Activated signaling pathways in HemSCs after macrophage conditioned media (CM) treatment. Western blot analysis (b), EdU incorporation (c), and tube
formation assays (d) of HemSCs pretreated with vehicle, LY294002 (10 μM) or PD98059 (10 μM) for 1 hour, then cultured with macrophage CM in indicated
medium for 24 hours with inhibitors. (e) Oil red staining of HemSCs treated with CM in adipogenic medium containing indicated inhibitors for 3 days, followed
by 11 days' culture in adipogenic medium. *Po0.05; **Po0.01 versus control group treated with vehicle; #Po0.05; ##Po0.01 versus control group treated with
M1- or M2-CM, respectively. Scale bar=100 μm.
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previous report that VEGFR-1 mediates endothelial differen-
tiation in an Erk1/2-dependent manner (Boscolo et al., 2011),
we speculated that Akt and Erk1/2 signaling pathways may
regulate the proliferation and differentiation of HemSCs,
respectively. Therefore, EdU incorporation, tube formation
and adipogenic induction assays were carried out to test this
hypothesis. As expected, LY294002 signiﬁcantly reduced the
incorporation of EdU in HemSCs treated with macrophage
CM, whereas PD98059 impaired the tube formation ability
of HemSCs and rescued the suppressed adipogenesis
(Figure 4c–e).
To further identify the possible factors involved in the
suppression of HemSC adipogenesis, a speciﬁc inhibitors of
PDGFR Crenolanib and TNF-α neutralizing antibody were
used during adipogenesis induction. Crenolanib (100 nM)
rescued the suppressed adipogenesis induced by both types of
macrophages (Supplementary Figures 8a and b online). The
activated Akt and Erk1/2 signaling pathways were also
signiﬁcantly suppressed in the presence of Crenolanib
(Supplementary Figure 8e online). This observation suggests
that PDGF has an important role in the suppression of
adipogenesis mediated by macrophages. TNF-α neutralizing
antibody (10 ngml−1) partially rescued the suppressed
adipogenesis in HemSCs treated with CM from M1-
polarized macrophages but not in those treated with CM
from M2-polarized macrophages. Moreover, PPARγ expres-
sion was partially restored by the TNF-α neutralizing antibody
in the group treated with CM from M1-polarized macro-
phages (Supplementary Figures 8c, d, and f online).
Macrophages regulate IH progression in the murine
hemangioma model
As shown in Figure 5a, the tumors that contained HemSCs
and THP-1 cells (THP-1 group) showed higher vascularization
of the Matrigel implants compared with the tumors that
contained only HemSCs (control group). Furthermore, M1-
and M2-polarized macrophages were detected in the THP-1
group (Figure 5b and Supplementary Figure 11 online). Anti-
human CD31 and anti-mouse CD31 antibodies were used to
distinguish vasculogenesis and angiogenesis in the tumor on
day 7. As shown in Figure 5c and e, more vessels with human
CD31-positive cells were found in the THP-1 group than in
the control group. However, negative staining of mouse CD31
in both control and THP-1 groups suggested the virtual lack of
mouse blood vessel formation in the Matrigel. The pro-
angiogenic factors vascular endothelial growth factor (VEGF)-
A and matrix metallo proteinase 9 were highly expressed in
the THP-1 group (Supplementary Figure 12b online). Quanti-
tative analysis by counting microvessel density in the two
groups revealed that mixed macrophages signiﬁcantly
increased blood vessel formation (Figure 5d). In addition,
more cellular components were observed in the THP-1 group
than in the control group, indicating increased proliferation of
hemangioma cells (Figure 5c). The stronger staining of cyclin
D1 in the THP-1 group further conﬁrmed that macrophages
promoted the proliferation of hemangioma cells. In the THP-1
group, the quantitative histoscores of cyclin D1 based on
staining range and intensity were 132, 141, 52, and 43 on
days 7, 14, 28, and 56, respectively, which were higher than
those in the control group (52, 53, 28, and 19 on days 7, 14,
28, and 56; Supplementary Figure 12a online).
We then evaluated the fat vacuoles and the expression of
PPARγ to explore the effects of macrophages on tumor
regression. Reduced fat vacuole formation and PPARγ
expression were observed in the THP-1 group on Day 14
(Figure 5e and Supplementary Figure 12c online). Real-time
PCR revealed decreased mRNA expression levels of PPARγ,
C/EBPα, and LPL in the THP-1 group (Supplementary
Figure 12d online). Collectively, our ﬁndings suggest that
macrophages in the murine hemangioma model regulate
the progression of IHs by promoting the proliferation
and vasculogenesis while suppressing the adipogenesis of
HemSCs.
Activation of the Erk1/2 and Akt pathways in murine
hemangioma model and human IH
We ﬁrst veriﬁed the activation of signaling pathways in
the murine hemangioma model by immunohistochemistry.
The phosphorylation of both Erk1/2 and Akt was higher in
the implants collected from the THP-1 group than in those
obtained from the control group (Figure 6a). We next explored
the activation of Erk1/2 and Akt in human IH specimens. High
p-Erk1/2Thr202/Tyr204 expression was only found in the
endothelial cells of proliferating hemangioma tissues and in
some involuting specimens. Positive staining of p-AktSer473
was found in the endothelial cells and primitive cells in
proliferating IHs but not in involuting IHs (Figure 6b). Previous
studies also observed elevated activation of Erk1/2 and Akt
signaling pathways in proliferating IHs than in involuting
His (Arbiser et al., 2001; Boscolo et al., 2011; Greenberger
et al., 2011). p-AktSer473, p-Erk1/2Thr202/Tyr204, CD68, HLA-
DR, CD163, Ki67, VEGF, and PPARγ in 13 IH samples
(including 6 proliferating tissues and 7 involuting tissues) were
subjected to cluster analysis and then visualized using
Treeview 1.0.5 (Standford, CA) (Figure 6c). The heat map
shows that the macrophage markers CD68, HLA-DR, and
CD163 were clustered, immediately followed by the cluster of
Ki67 and p-AktSer473 and then the cluster of VEGF and
p-Erk1/2Thr202/Tyr204. The cluster of PPARγ was distant from
the other clusters. These results suggest a possible link
between HemSC proliferation and Akt signaling, as well as
between HemSC differentiation and Erk1/2 signaling. The
same ﬁndings also indicate the association between the
functions of macrophage and other related molecules in IHs.
DISCUSSION
Macrophages can support the survival and regulate the
proliferation and differentiation of various types of stem cells
(Ehninger and Trumpp, 2011; Lu et al., 2014). In the present
study, both M1- and M2-polarized macrophages simulta-
neously enhanced the proliferation and prevented the
adipogenesis of HemSCs. Moreover, M2-polarized but not
M1-polarized macrophages promoted the endothelial differ-
entiation of HemSCs. After mixing monocytes and HemSCs in
Matrigel and injecting them into nude mice subcutaneously,
we demonstrated that the mixed monocytes, which later
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differentiated into macrophages, signiﬁcantly enhanced the
proliferation and vasculogenesis of hemangioma cells while
suppressing fatty tissue formation. These ﬁndings suggest that
the inﬁltrating macrophages in IHs promote the progression of
the disease by enhancing the proliferation and vasculogenesis
of the stem cells.
Growth factors and cytokines have important roles in
intercellular communication, which may contribute to the
ability of macrophages to regulate the proliferation and
differentiation of HemSCs. In this study, various growth
factors and inﬂammatory cytokines were expressed in the
macrophages (Supplementary Figure 9 online). Platelet-
derived growth factor (PDGF) was highly expressed in the
activated macrophages, and an increase in phosphorylation of
PDGFR-β was observed in the HemSCs after treatment with
macrophage CM (Supplementary Figure 7 online). Consistent
with a previous study in which PDGF promoted the
proliferation and self-renewal, whereas suppressed the
adipogenesis of mesenchymal stem cells (Gharibi et al.,
2012), we showed that PDGF suppressed the adipogenesis of
HemSCs induced by polarized macrophages (Supplementary
Figure 8 online). Furthermore, inﬂammatory cytokines parti-
cipate in the differentiation of stem/progenitor cells (Al-Lamki
et al., 2013; Kim et al., 2013; Ventayol et al., 2014), including
adipogenesis (Floyd et al., 2007; van Asseldonk et al., 2010).
In the present study, TNF-α antibody can partially rescue the
suppressed adipogenesis of HemSCs induced by M1-
polarized macrophages (Supplementary Figure 8 online). This
ﬁnding suggests that inﬂammatory cytokines are involved in
the effects of macrophages on HemSCs. We speculate that the
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impact of macrophages on HemSC proliferation and differ-
entiation may result from integrated effects of various factors.
The activation of signaling pathways in the HemSCs after
treatment with macrophage CM were analyzed. The phos-
phorylation levels of Erk1/2 and Akt were increased by CM
treatment. Previous studies suggested that Erk1/2 serves as a
key component in regulating the pluripotency of embryonic
stem cells (Li et al., 2010; Jiang et al., 2013). In the present
study, we showed that suppressing Erk1/2 decreases VE-
cadherin expression but rescues PPARγ expression. This
observation implies that the Erk1/2 signaling pathway has a
crucial role in the differentiation of HemSCs, including their
vasculogenesis and adipogenesis. The activation of Erk1/2 in
proliferating hemangioma tissues was reported in several
previous studies (Arbiser et al., 2001; Boscolo et al., 2011).
Moreover, the activation of Erk1/2 in HemSCs facilitates their
endothelial differentiation (Greenberger et al., 2011). The
present data also suggest that Akt activation enhances the
proliferation of HemSCs. Akt and its downstream target
mTOR have highly important roles in tumor angiogenesis
(Arbiser et al., 1997) and vascular malformations (Perry et al.,
2007); they are also highly expressed in proliferating IHs
(Greenberger et al., 2011). We previously demonstrated that
mTOR activation prevents the apoptosis of endothelial cells in
human IH tissues (Chen et al., 2013). Moreover, mTOR
regulates the self-renewal and vasculogenic potential of
HemSCs, and its speciﬁc inhibitor rapamycin exerts excellent
curative effects in cellular and animal models (Greenberger
et al., 2011). Meanwhile, the non-speciﬁc beta-blocker
propranolol cures severe IHs (Leaute-Labreze et al., 2013;
Vercellino et al., 2013). Propranolol possibly prevents IH
progression by suppressing both Akt and Erk1/2 pathways
(Zou et al., 2013).
In summary, our study presented the ﬁrst evidence for the
essential role of macrophages in regulating the proliferation,
vasculogenesis, and adipogenesis of HemSCs; this role
may be associated with the activation of Erk1/2 and Akt
signaling pathways (Supplementary Figure 13 online). These
ﬁndings indicate that targeting the inﬁltrating macrophages
may be a promising remedial approach for IHs and other
vasculogenesis-related diseases.
MATERIALS AND METHODS
Clinical samples, immunohistochemistry, and
immunoﬂuorescence
Thirteen clinical samples of IH were collected at Hospital of
Stomatology, Wuhan University (Supplementary Table 1 online).
The study was approved from the review board of the ethics
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committee of Hospital of Stomatology, Wuhan University. Written
informed consent was obtained from all parents or primary caregivers
for use of IH specimens.The procedures for human tissues were
performed according to the National Institutes of Health guidelines.
The diagnosis and classiﬁcation of each sample were conﬁrmed in
Department of Pathology. Immunohistochemistry and immunoﬂuor-
escence were performed as previously described (Jia et al., 2008).
Cell isolation and culture
Human IH stem cells were derived from the proliferating heman-
gioma tissues which were collected at Hospital of Stomatology,
Wuhan University, according to the protocol reported by Khan et al.
(2008) with minor modiﬁcation. Human dermal ﬁbroblast-neonatal
(NDF) were purchased from ScienCell (San Diego, CA). The human
umbilical vein endothelial cells were isolated and cultured as we
previously reported (Chen et al., 2013). THP-1 cell line was
purchased from the China Center for Type Culture Collection
(CCTCC, Wuhan, China). The procedure for macrophage polariza-
tion induction was described in the Supplementary Materials online.
For collection of CM, the medium of THP-1 cells after polarization
induction were replaced by EBM-2 supplemented with 2% FBS and
cultured for another 24 hours. Then the medium were collected and
ﬁltered with 8-μm cell strainer. EBM-2 supplemented with 2% FBS
(termed as EBM-2/2% FBS) were used as control medium.
MTT and EdU incorporation assays
For MTT assays, 3,000 cells per well were plated onto 96-well plates.
After treatment, MTT solution was added for 4 hours incubation. The
precipitate was dissolved with dimethylsulfoxide (Sigma-Aldrich, St
Louis, MO) and the absorbance was measured at 490 nm (BioTek,
Winooski, VT). For EdU incorporation assays, the proliferating
HemSCs were determined using the Cell-Light EdU Apollo 488
In Vitro Imaging Kit (Ribobio, Guangzhou, China) according to the
manufacturer’s instruction.
Tube formation assays
For tube formation assays, HemSCs were seeded on 48-well plates
coated with Matrigel at 3× 103 cells per well, and then treated with
control medium or CM for 18 hours. Then the capillary-like structures
were photographed under a light microscope (Leica, Wetzlar,
Germany), and the tubes were scanned and quantitated using
Image-Pro Plus 6.0 (Media Cybernetics, Rockville, MD).
Adipogenic differentiation and Oil red O staining
For induction of adipogenic differentiation, HemSCs were pre-
cultured in 24-well plates till over conﬂuence for 2 days, and then
induced with adipogenic medium (ScienCell, San Diego, CA), and
stained with oil red O solution according to the manufacturer’s
instruction. For quantitative analysis, cells were then lysed with
isopropanol and the absorbance was measured at 490 nm using a
96-well microplate reader (BioTek).
Murine model for human IH
Male BALB/c nude mice (18–20 g; 6–8-weeks old) were purchased
from the Center for Animal Experiment of Wuhan University in
pressurized ventilated cages according to institutional regulations. All
studies were approved and overseen by the Institutional Animal
Care and Use Committee, Center for Animal Experiment, Wuhan
University. In all, 2× 106 HemSCs (or 1.6× 106 HemSCs and
0.4× 106 THP-1 cells) were trypsinized and resuspended in 200 μl
phenol red-free Matrigel (BD Biosciences, San Jose, CA). The mixture
was injected into the ﬂaps of nude mice subcutaneously (eight
animals for each group). Animals were killed and Matrigel plugs were
collected at 7, 14, 28, and 56 days. The Matrigel plugs were ﬁxed
and embedded for H&E staining and immunohistochemisty, or
isolated in TRIzol (Invitrogen, Carlsbad, CA) for RNA extraction and
real-time PCR analysis (Applied Biosystems, Carlsbad, CA). The
samples were validated by H&E staining and immunohistochemisty
as shown in Supplementary Figure 10 online.
Statistical analysis
Data were analyzed with Graph Pad Prism version 5.00 for Windows
(Graph-Pad Software, La Jolla, CA). Student t-tests were performed
to analyze the difference between two groups. Two-way analysis of
variance analysis was used to analyze the grouped results. Po0.05
was considered statistically signiﬁcant.
Please ﬁnd more details in Supplementary Materials online.
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